Smoking is no excuse not to give biologics in AS

Response to TNF inhibitors does not differ according to smoking status in a study of patients with axial spondyloarthritis (axSpA). However smokers and ex-smokers start from a different baseline of disease severity than never smokers. The study of 627 patients from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis commencing on their first ...

Already a member?

Login to keep reading.

© 2021 the limbic